Immunologic rebound after cessation of long-term chemotherapy in acute leukemia.
D000293:Adolescent; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D001856:Bone Marrow Examination; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D005779:Immunodiffusion; D007136:Immunoglobulins / Q000032:analysis; D007156:Immunologic Memory; D007165:Immunosuppression Therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009975:Orthomyxoviridae; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D000906:Antibodies; D007136:Immunoglobulins; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate